Stephen Pitt, Ph.D. Email and Phone Number
Senior pharmaceutical R&D leader with demonstrated results building external innovation strategies and therapeutic area pipelines via partnerships with startups, biotechs, and academia that leverage preclinical and clinical stage assets. Strong ability to identify and catalyze synergistic value with external partners to deliver strategically aligned assets that gain internal executive-level funding and expand overall business strategies. Established external innovation and alliance management teams, directed healthcare startup incubators, and led cross-functional teams in drug discovery and pharmaceutical development. Recognized thought leader, board member, and innovation ecosystem advisor currently focused on interventional oncology.
-
Global Head Of Search And EvaluationCslNew York, Ny, Us
-
Global Head Of External Innovation/Alliance Management, Interventional Oncology At J&JJohnson & Johnson 2023 - PresentNew Brunswick, Nj, UsLeading a team that builds a robust portfolio of strategically aligned external INTO assets; responsibilities include landscaping, search & evaluation, cross-functional due diligence assessments, scientific/clinical evaluations, IP strategy, building/shaping the external community, competitive intelligence, partnering with transactors through deal close, alliance management post-deal, ensuring Joint Steering Committees deliver key milestones, etc. Delivered 15+ external deals focused on intratumoral drug delivery. -
Global Head Of Pharmaceutical Sciences External Strategy, Lung Cancer Initiative At J&JJohnson & Johnson 2022 - 2023New Brunswick, Nj, UsLed the External Innovation Team for the Lung Cancer Initiative (a cross-enterprise convergence of Pharma & MedTech sectors) developing interventional oncology approaches that provide superior outcomes in lung and other tumor types
-
Head Of Jlabs @ Us North East (Nyc, Boston, & Philadelphia), Johnson & Johnson InnovationJohnson & Johnson 2019 - 2022New Brunswick, Nj, UsLed incubation initiatives across the Northeast US region to connect cutting edge external science & technologies with all J&J businesses; Incubated 100+ healthcare startups at 5 sites; Built a strategically aligned start-up portfolio that resulted in over 13 deals with J&J (including research collaborations, asset deals, newco creation, and equity investments)
-
Global Head Of Emerging Science & Digital Innovation, R&DGsk 2017 - 2019Brentford, Middlesex, GbSenior DirectorBuilt and led two distinct innovation teams that translated scientific breakthroughs into high-value business results by delivering transformational projects (>$575MM pipeline value) via newly established breakthrough technology platforms -
Global Head Of Emerging Science Innovation, R&DGsk 2016 - 2017Brentford, Middlesex, GbDirectorShifted pipeline strategies from basic symptom relief to holistic OTC disease management; developed various digital health & diagnostic technology platforms that enabled monitoring, prediction, prevention, and personalized medicine
-
Global Innovation Lead For Allergy & Pain, R&DJohnson & Johnson 2013 - 2016New Brunswick, Nj, UsLed Global Innovation & Drug Development Teams that developed OTC drug global pipeline strategies in partnership with Janssen Pharmaceuticals
-
Medical Dermatology & Device Innovation Lead, Ortho Dermatologics (Janssen Pharmaceuticals)Johnson & Johnson 2010 - 2013New Brunswick, Nj, UsLed innovation, pipeline strategy and end-to-end development of NCEs, medical devices, and life cycle management for Rx Dermatology and Wound Care
-
Head Of In Vivo Pharmacology & Pharmaceutical Development, Drug DiscoveryPalatin Technologies 2007 - 2010UsDirector (2010)Associate Director (2007-2010)Collaborated with AstraZeneca by leading Preclinical Pharmacology and Pharmaceutical Development functions to discover anti-obesity NMEs (peptides & small molecules); joint team discovered & advanced compounds to IND enabling studies and Phase 1 clinical trials -
Pharmaceutical Development Lead, Rx Ophthalmology & Ortho Dermatologics (Janssen Pharmaceuticals)Johnson & Johnson 2004 - 2007New Brunswick, Nj, UsPrincipal Scientist (2006-2007) Staff Scientist (2004-2006)Selected/evaluated NCE candidates from the overall J&J pharmaceutical pipeline to develop novel topical drug products; managed the development of 3 NCEsCross-functional team leader for the development of the marketed prescription ophthalmic drug product Lastacaft® (Alcaftadine Ophthalmic Solution, 0.25%) from pre-clinical studies through registration
-
Pharmaceutical R&D Scientist, Early Oral Drug Discovery CandidatesPfizer 1998 - 2000New York, New York, UsAssistant Scientist II (2000)Assistant Scientist I (1998-2000) -
Pharmaceutical R&D Scientist, Drug Product Analytical ChemistryBayer 1996 - 1998Leverkusen, North Rhine-Westphalia, DeAnalytical Chemist VII (1997-1998)Analytical Chemist VI (1996-1997)
Stephen Pitt, Ph.D. Education Details
-
Cornell UniversityJoint Program With Memorial Sloan Kettering Cancer Center -
Trinity College-HartfordBiochemistry
Frequently Asked Questions about Stephen Pitt, Ph.D.
What company does Stephen Pitt, Ph.D. work for?
Stephen Pitt, Ph.D. works for Csl
What is Stephen Pitt, Ph.D.'s role at the current company?
Stephen Pitt, Ph.D.'s current role is Global Head of Search and Evaluation.
What schools did Stephen Pitt, Ph.D. attend?
Stephen Pitt, Ph.D. attended Cornell University, Trinity College-Hartford.
Who are Stephen Pitt, Ph.D.'s colleagues?
Stephen Pitt, Ph.D.'s colleagues are David Rimmer, Mathulan Manoharan, Dana M., Joy Quinal, Simon Morris, Pamela Debartolo, Vincent Heflin.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial